Table 2.
Symptoms and physical examination upon admission between groups before and after propensity score matching
| All cohort | Propensity score matched cohort | |||||||
|---|---|---|---|---|---|---|---|---|
| ASA | No ASA | % or mean difference | p value | ASA | No ASA | % or mean difference | p value | |
| Cough, n (%) | 2148 (65.3) | 12,534 (72.2) | − 6.9% | < 0.001 | 2148 (65.3) | 1864 (64.6) | + 0.7% | 0.588 |
| Arthromyalgias, n (%) | 736 (22.4) | 5375 (31) | − 8.6% | < 0.001 | 736 (22.4) | 637 (22.1) | + 0.3% | 0.789 |
| Ageusia, n (%) | 184 (5.6) | 1730 (10) | − 4.4% | < 0.001 | 184 (5.6) | 164 (5.7) | − 0.1% | 0.874 |
| Anosmia, n (%) | 151 (4.6) | 1535 (8.8) | − 4.2% | < 0.001 | 151 (4.6) | 146 (5.1) | − 0.5% | 0.387 |
| Sore throat, n (%) | 230 (7) | 1683 (9.7) | − 2.7% | < 0.001 | 230 (7) | 209 (7.2) | − 0.2% | 0.697 |
| Headache, n (%) | 230 (7) | 2264 (13) | − 6% | < 0.001 | 230 (7) | 196 (6.8) | + 0.2% | 0.763 |
| Fever, n (%) | 2487 (75.6) | 14,261 (82.2) | − 6.6% | < 0.001 | 2487 (75.6) | 2168 (75.1) | + 0.5% | 0.701 |
| Dyspnea, n (%) | 1928 (58.6) | 10,200 (58.8) | − 0.2% | 0.826 | 1928 (58.6) | 1685 (58.4) | + 0.2% | 0.887 |
| Diarrhea, n (%) | 692 (21) | 4257 (24.5) | − 3.5% | < 0.001 | 692 (21) | 588 (20.4) | + 0.6% | 0.532 |
| Vomiting, n (%) | 246 (7.5) | 1367 (7.9) | − 0.4% | 0.429 | 246 (7.5) | 210 (7.3) | + 0.2% | 0.769 |
| Abdominal pain, n (%) | 179 (5.4) | 1128 (6.5) | − 1.1% | 0.022 | 179 (5.4) | 188 (6.5) | − 1.1% | 0.074 |
| Heart rate, bpm median [IQR] | 83 [73–95] | 88 [77–100] | − 5 | < 0.001 | 83 [73–95] | 84 [74–95] | − 1 | 0.077 |
| Respiratory rate > 20 bpm, n (%) | 1142 (34.7) | 5429 (31.3) | + 3.4% | < 0.001 | 1142 (34.7) | 1037 (35.9) | − 1.2% | 0.307 |
ASA Acetylsalicylic acid, IQR interquartile range